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1. Introduction 
Cardiovascular diseases are prevalent conditions which impose significant negative impacts 
on the healthcare system. According to World Health Organization (WHO), non-
communicable diseases (NCD) including cardiovascular diseases account for more than 60% 
of all deaths globally. Overweight/obesity, diabetes, hypertension and dyslipidemia are all 
traditional cardiovascular risk factors in adults. Of particular concern, adolescence obesity 
and its associated cardiovascular risk and co-morbidities have substantial tracking into 
adulthood (1-4).  
Advances in technology of agriculture have helped to increase food production resulting in 
easily available, excessive provision of food in many developed countries. Urbanization also 
leads to changes in leisure activities from doing sports to television viewing and computer 
games. As a consequence to increasing demand from school and leisure activities, sleep 
deprivation is another novel risk factor contributing to the escalation of cardiovascular risk 
in the youth populations. In addition, exposure to heavy metals is increasingly recognized 
as a consequence of urbanization and may contribute to premature atherosclerosis.  
2. Traditional cardiovascular risk factors in adolescents 
2.1 Overweight and obesity 
Overweight/obesity is an important and well-known cardiovascular risk factor in children, 
adolescents and adults. Obesity is closely associated with clustering of cardiovascular risk 
factors with insulin resistance being the possible link(5). Obesity is also associated with 
increased risk of a number of co-morbidities and premature mortality in both adult and the 
youth populations (2, 6-11). In a British cohort followed up for 57 years, overweight in 
childhood was associated with 1.5 times increased risk of all-cause mortality and two-fold 
increased risk of ischemic heart disease (6). Co-morbidities of adolescence obesity include 
type 2 diabetes mellitus, micro-inflammation, atherogenic dyslipidemia, hypertension, left 
ventricular hypertrophy, premature atherosclerosis leading to cardiovascular diseases, 
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obstructive sleep apnoea, gastroesophageal reflux disease, depression and other 
psychosocial abnormalities (2, 12-16). Clustering of traditional cardiovascular risk factors, 
namely metabolic syndrome, is noted to have ethnic disparities (17)and the prevalence also 
varies according to the different definitions of metabolic syndrome adopted(11, 18). Despite 
the controversies regarding the exact definitions of metabolic syndrome in both adults and 
children(19, 20), International Diabetes Federation (IDF) recently suggests abdominal 
obesity as the core criteria in making a diagnosis of metabolic syndrome(21), highlighting 
the pivotal role of obesity in linking these cardiometabolic abnormalities and cardiovascular 
diseases.  
Childhood obesity can predict the cardiovascular risk in adulthood (22). With increasing 
childhood obesity, there is increasingly early onset of atherosclerosis(23). In a study 
involving Hong Kong Chinese overweight children aged 9-12 years (mean BMI 25 ± 3 
kg/m2),  BMI was independently associated with impaired arterial endothelial function and 
increased carotid intimal medial thickness, which are early markers of atherosclerosis (24). 
An important message from this study is that these obesity-related early vascular 
dysfunctions are partially reversible by lifestyle modifications (25).  
Prevalence of childhood and adolescence overweight/obesity has marked variation among 
developed and developing countries. The prevalence of childhood and adolescence obesity 
has tripled between 1980 and 2000 in United States (US) and doubled between 1985 and 
1995 in Australia(26). In a systemic review of published literatures examining data of 
prevalence of overweight/obesity among children living in developing countries, lowest 
prevalence was found in India and Sri Lanka whereas highest prevalence was found in 
Eastern Europe and the Middle East(27).When comparing epidemiological and clinical 
studies examining childhood and adolescence overweight/obesity, the diagnostic criterion 
used to define overweight/obesity should be interpreted with cautions.  Despite the 
importance to identify overweight/obese individuals and screen for associated 
cardiovascular risk factors early, there is no consensus regarding the diagnostic criteria of 
childhood and adolescence obesity (28). Compared to adults, assessment of overweight and 
obesity in children and adolescents are different and not that straightforward. We need to 
take growth and puberty into consideration because BMI is anticipated to change with age 
and depends on gender. Gender difference is particularly important in the assessment of 
childhood and adolescence obesity as girls and boys enter puberty at different pace. In 
children and adolescents, there are ongoing debates regarding the optimal cutoff values of 
BMI and waist circumference (WC) to define childhood and adolescence overweight and 
obesity with various diagnostic criteria adopted by different countries and authorities (28-32).  
From published pediatric literatures, at least four diagnostic criteria have been used for the 
definition of overweight and obesity in children and adolescents (11, 28): 
1. An international BMI-for-age reference curve for defining overweight and obesity in 
children 2 to 18 years of age by the US National Center for Health Statistics, Centers for 
Disease Control and Prevention (CDC) and the International Obesity Task Force (IOTF) 
in 2000 (IOTF criteria) (31).  
These criteria were based on median BMI by age and gender in six nationally representative 
datasets from Brazil, Hong Kong, Netherlands, Singapore,  United Kingdom (UK) and the 
US from an international growth survey in 2000. These surveys had over 10,000 subjects 
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each and altogether covered 97,876 boys and 94,841 girls. Overweight and obesity were 
defined as BMI-for-age ≥25 and ≥30 kg/m2 respectively. 
2. A national BMI reference curve for Chinese children and adolescents reported by the 
Group of China Obesity Task Force (COTF) in 2004 (COTF criteria) (33).  
These criteria were based on the Chinese National Survey on Students Constitution and 
Health in 2000 involving 244,200 primary and secondary Chinese students aged 7–18 years. 
Overweight and obesity were defined as BMI-for-age ≥24 and ≥28 kg/m2 respectively. 
3.  CDC 2000 Growth Charts for the US (CDC criteria) (34).  
These criteria were based on the US National data collected in a series of 5 surveys between 
1963 and 1994 for children and adolescents aged 2–20 years. Overweight and obesity were 
defined as BMI-for-age ≥85th and ≥95th percentiles respectively. 
4. The Hong Kong Growth Survey (HKGS) conducted in 1993 with sex-specific reference 
charts of weight-for-height (HKGS criteria) (35).  
This was a territory-wide cross-sectional growth survey which covered around 25,000 Hong 
Kong Chinese children from birth to 18 years of age. Childhood obesity in this survey was 
defined as weight > median weight for height × 120%. No definition for childhood 
overweight was set in this survey. 
In recent years, increasing clinical attention has been drawn to central obesity because 
central body fat is a better predictor than overall body fat for cardiovascular risk factors in 
both adults (36, 37) and children (7, 38, 39). Central obesity reflects excess visceral adiposity 
which is a major culprit for insulin resistance and associated cardiovascular disease in both 
adults and children (7, 38, 40-43). WC and WC-derived indexes such as waist-to-hip ratio 
(WHR) and waist-to-height ratio (WHTR) are commonly employed anthropometric 
measurements as proxy measures of central obesity. In Caucasian adults, WC ≥102cm in 
men and ≥ 88cm in women are used to define central obesity (1,3). The corresponding cutoff 
values in Chinese and South Asian men and women are ≥ 90cm and ≥ 80cm respectively (5, 
44). In adults, there are at least 14 different methods to quantify WC (19). In pediatric 
literatures, measurements of WC have been described at 5 different sites: 1) midway 
between the lowest rib and superior iliac crest (45-49); 2) at the umbilical level (50, 51); 3) at 
the narrowest point of the torso (52); 4) at the level of the right upper iliac crest (53); and 5) at 
the level of 2 cm above the umbilicus (54). Based on the 2005/2006 Hong Kong Growth Survey 
including 14,842 Hong Kong Chinese school children aged 6 to 18 years, reference values and 
percentile curves for WC and WHRT are established (49). These charts are based on WC 
measured midway between the lowest rib and superior iliac crest and provide reference 
values for estimation of central obesity in local Hong Kong Chinese youth populations.  
In summary, adolescence obesity is a global concern because obesity associated 
cardiovascular risk factors and abnormalities are potentially reversible in early disease 
stage. Despite the epidemic of childhood and adolescence obesity worldwide, the most 
appropriate criterion to ascertain the diagnosis is still inconclusive. Given the high rates of 
adolescence obesity, adolescents are important population for monitoring and 
intervention.  
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2.2 Diabetes 
Diabetes is a disorder of glucose metabolism with complex interplays between genetic, 
lifestyle and environmental factors. Historically, type 2 diabetes is much less common in 
children and adolescents compared to autoimmune type 1 diabetes and type 2 diabetes has 
once been thought to be non-existent in children (55). However, with increasing prevalence 
of obesity worldwide, type 2 diabetes in children and adolescents is increasing at an 
alarming pace (55). Atherosclerosis starts in young people with type 2 diabetes(56). The 
general awareness of type 2 diabetes in adolescents should be escalated, particularly in those 
with obesity and family history of type 2 diabetes. American Diabetes Association (ADA) 
(57)has recommended the testing for type 2 diabetes in asymptomatic children and 
adolescents who are: aged 10 years or at onset of puberty, overweight (BMI>85th percentile 
for age and sex, weight for height >85th percentile, or weight>120% of ideal for height), plus 
any two of the following risk factors: 
1. family history of type 2 diabetes in first- or second-degree relative; 
2. race/ethnicity (Native American, African American, Latino, Asian American, Pacific 
Islander); 
3. clinical evidence and/or association of insulin resistance, e.g. polycystic ovarian 
syndrome, metabolic syndrome, acanthosis nigricans, etc; 
4. maternal history of gestational diabetes during the child’s gestation.  
ADA recommends a three yearly screening in these at-risk young individuals (57). In 
making the diagnosis of diabetes in adolescents, the possibility of “hybrid” disease with 
obesity and concomitant diseases with compromised insulin secretion such as maturity-
onset diabetes of the young (MODY) or latent autoimmune diabetes in adult (LADA) should 
always be considered(58).  
For adolescents with type 1 diabetes who present with acute decompensation and diabetic 
ketoacidosis (DKA), insulin therapy is the standard therapy. Insulin use is also advised in 
youth with type 2 diabetes who present with severe hyperglycemia (≥11.1 mmol/L), 
HbA1c>8.5% or severe manifestation of insulin deficiency such as DKA (59). Although oral 
antidiabetic agents are not recommended in treatment of type 1 diabetes traditionally, 
metformin use in conjunction with insulin in adolescents with poorly controlled diabetes 
has been reported to improve their glycemic control (60). Despite the escalating rate of type 
2 diabetes in the youth, therapeutic modalities remain limited with metformin being the 
only U.S. Food and Drug Administration (FDA)-approved oral treatment for youth with 
type 2 diabetes (61). Similar recommendation has been adopted in other countries (62).  
2.3 Hypertension 
The global epidemic of obesity is leading to a shift in the diabetes, as well as hypertension 
distribution towards increasing levels in children and adolescent (63, 64). In addition, 
physical inactivity and high salt/sodium intake contribute to the rise in the prevalence of 
hypertension in the youth. Similar to childhood and adolescence obesity, there is also 
tracking of high blood pressure from childhood into adulthood(65, 66). Autopsy findings 
from Bogalusa Heart Study and the Pathobiologic Determinates of Atherosclerosis in Youth 
(PDAY) have shown that higher blood pressure in the youth populations is associated with 
increased atherosclerosis(67, 68).  
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Accurate measurement of blood pressure and correct diagnosis of hypertension or pre-
hypertension in the youth populations are important to prevent end-organ damage in 
adults. The fourth report on the diagnosis, evaluation and treatment of high blood pressure 
in children and adolescents has suggested a diagnosis of hypertension as >95th percentile for 
gender, age and height on ≥ 3 occasions. Stage 1 hypertension is diagnosed if systolic or 
diastolic blood pressure reaches 95th to 99th percentile plus 5 mmHg on at least 3 separate 
occasions(69) whereas stage 2 hypertension is defined as >99th percentile plus 5mmHg. 
Various diagnostic cutoff values have been suggested for defining hypertension and pre-
hypertension in the youth population (Table 1). Pre-hypertension is defined as >120/80 
mmHg or ≥ 90th to <95th percentile (69). Blood pressure increases with age, yet there is 
limited information regarding the time course for children and adolescents with pre-
hypertension to progress to hypertension. For early diagnosis of pre-hypertension and 
hypertension, reference blood pressure standards by sex-, age-, weight- and height are 
clinically important (70, 71).  
 
The 4th report on the 
diagnosis, 
evaluation, and 
treatment of high 
BP in children and 
adolescents(69) 
Cool et al (76) , 
(77) and Kong et 
al (39, 78) 
Cruz et al (79) 
and de Ferranti 
et al (75) 
Weiss et al (80) Zimmet et al 
(21) 
BP > 95th percentile 
for gender, age and 
height on >3 
occasions 
BP ≥ 90th 
percentile for 
gender, age and 
height 
BP > 90th 
percentile for 
gender, age and 
height 
BP > 95th 
percentile for 
gender, age and 
height 
BP≥ 130/85 
mmHg 
Table 1. Diagnostic criteria used in pediatric literatures for definition of hypertension. Blood 
pressure: BP. 
White coat hypertension is a well recognized phenomenon of transiently high blood 
pressure related to stress. Home-clinic blood pressure difference can vary substantially by 
age in children with the difference reduced with advancing age and substantially diminshed 
after 12 year-old(72). Therefore, ambulatory blood pressure (AMBP) is gaining popularity in 
both children and adults due to the stronger correlation between high AMBP with target 
organs damage observed in an emerging number of studies in both adults and paediatric 
populations (73).  
For youth with pre-hypertension and hypertension, a search and thorough evaluation for 
secondary causes is recommended as secondary hypertension is more common in children 
than adults(69). If secondary hypertension is ruled out, children and adolescents with pre-
hypertension should start lifestyle modifications(69). For stage 2 hypertension, drug therapy 
should be initiated but for those with stage 1 hypertension, pharmacological treatment is 
recommended if symptomatic, evidence of end-organ damage, concomitant diabetes or 
persistent high blood pressure despite non-pharmacological measures(69). A detailed 
elaboration of the dosage, dosing interval and precautions of different types of 
antihypertensive drugs for children with hypertension has been described in the fourth 
report on the diagnosis, evaluation and treatment of high blood pressure in children and 
adolescents(69).  
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2.4 Dyslipidemia 
Dyslipidemia continue to track from childhood into adulthood(74). Similar to the 
controversies in diagnosis of obesity and hypertension, there is no consensus regarding the 
definition of dyslipidemia in children and adolescents. Typical dyslipidemia in children and 
adults with obesity and insulin resistance include increased triglyceride and decreased high-
density lipoprotein (HDL) cholesterol levels. The definitions of high triglyceride level in the 
youth range from ≥ 1.1 mmol/l (ie ≥ 100 mg/dL) (75), ≥ 1.2 mmol/l (39, 76, 77) to ≥ 1.7 
mmol/l (21, 39, 78). Some researchers adopt age-, sex- and/or race-specific percentile cutoff 
to diagnose hypertriglyceridemia with triglyceride ≥ 90th percentile (79)and >95th percentile 
(80) used. For defining low HDL cholesterol levels in the pediatric literatures, a cutoff value 
of ≤ 1.03 mmol/l (ie< 40mg/dL) for all ages/sexes (39, 76-78), < 1.03 mmol/l (21), <1.3 
mmol/l (ie <50mg/dL)(75), or gender-specific cutoff ≤ 1.03 mmol/l for boys and ≤ 1.3 
mmol/l for girls (81), or percentile specific cutoff <5th percentile (age-, sex- and race- 
specific)(80) and ≤ 10th percentile (age-, sex- and height-specific) (79, 82) have been reported.  
Low density lipoprotein (LDL) cholesterol remains to be the primary target of lipid control 
to prevent cardiovascular events in adults (83). Hence, majority of randomized controlled 
trials carried out in pediatric populations have also focused on the use of statins in youth 
with elevated LDL cholesterol levels. There is general consensus that statin should be 
initiated, in combination with diet and lifestyle modification if LDL cholesterol level > 4.1 
mmol/l (ie 160mg/dl) in at-risk youth (84, 85). Fibrates and niacin are lipid lowering drugs 
targeted to treat high triglyceride and low HDL cholesterol in adults, but neither drugs is 
approved for use by US FDA in the pediatric population.  
3. Novel cardiovascular risk factors in adolescents 
3.1 Sleep 
Physiologically, average sleep duration decreases with progression from infancy, childhood 
to adolescence (86). With increasing demand from school and work, as well as changes in 
leisure activities such as television watching and computer games, the average sleep 
duration in the US adults has decreased from 9 hours per night a century ago to 6.9 hours 
per night in 2005 (87). In Sweden, the average sleep time has decreased from 9 hours per 
night in 1910 to 7.5 hours in 1990’s in adults aged 20-64 years (88).  
Sleep deprivation is now increasingly recognized as a lifestyle factor contributing to the 
global epidemic of childhood obesity and a novel, potentially reversible cardiovascular risk 
factor. Both laboratory and epidemiological studies suggested associations of obesity, 
insulin resistance, diabetes and cardiovascular disease with sleep debt in children, 
adolescents and adults (89-91). Increasing number of epidemiological studies show close 
association between sleep duration and obesity, which is evident as early as during early 
childhood (92-96). Short duration of sleep at age of 3 years predict future risk of obesity in 
childhood (92). In a Japanese study of 8274 children aged 6-7 years, an inverse relationship 
between hours of sleep and risk of childhood obesity was observed (93). Cross-sectional 
studies from US, Canada, UK, France, Germany and Japan suggest increased risk for 
overweight or obesity in Caucasian, Hispanic, African-American and Japanese children who 
sleep long hours than those with short sleep duration (93, 97-101). Prospective studies also 
suggest a predictive role of short sleep duration for overweight and obesity in Caucasians 
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children (92, 102). Similar data from Chinese children and adolescents are comparatively 
sparse. A recent survey in Taiwan involving 656 boys and girls aged 13-18 years showed 
that sleep deprivation (defined as sleep <6 hours on schooldays) was associated with poor 
health status as measured by health-related behaviors in self-reported questionnaires (103).  
Although the exact underlying mechanism linking sleep and obesity is not fully understood, 
preliminary results suggest a possible neurohormonal basis. There is evidence showing that 
sleep curtailment can activate the hypothalamo-pituitary-adrenal (HPA) axis (104). Van 
Cauter et al have demonstrated a significant rise in plasma cortisol levels in the following 
evening amongst subjects after partial (0400-0800 hours) and total sleep deprivation (37% 
and 45% increases, p=0.03 and 0.003 respectively) compared to those with normal sleep 
duration (2300-0700 hours) (104). In another study by Van Cauter et al, sleep debt was 
associated with adverse effects on carbohydrate metabolism and endocrine function (105). 
Glucose tolerance and thyrotropin concentrations were reduced while evening cortisol 
concentrations and activity of sympathetic nervous system were increased in the sleep debt 
group (4 hours per night) (105). Interestingly, these hormonal and metabolic changes are 
very similar to that accompanying normal ageing. Based on rodent studies, positive relation 
between sleep curtailment and hyperphagia has been noted. Van Cauter et al further 
demonstrated an inverse relationship between sleep debt and leptin, an important 
anorexigenic hormone secreted by adipocytes mediating the signals between adipose tissues 
and the hypothalamic regulatory centers (106, 107). In concert with this phenomenon, 
elevated ghrelin levels, the orexigenic hormone, were observed with reduced sleep duration 
accompanied by increased hunger and appetite (106). Similar results have also been 
reported by other workers showing associations between high BMI, short sleep duration, 
decreased leptin and elevated ghrelin levels (95). In addition, lipid and energy metabolism 
are regulated by circadian rhythm (108). Sleep problems may result in dysregulation of lipid 
metabolism and metabolic syndrome. In a national study in Japan, sleep duration in adults 
was closely related with serum lipid and lipoprotein levels (109). Recently, an association 
between atherogenic dyslipidemia and reduced sleep duration is reported in both U.S. and 
Hong Kong Chinese adolescents(110, 111).  
3.2 Inflammation 
Atherosclerosis can be regarded as a state of chronic, low-grade inflammation of the arterial 
wall, resulting from the interactions between plasma lipoproteins, peripheral blood 
mononuclear cells (PBMC) and the endothelium (112). It has been increasing recognized the 
clinical utility and prognostic role of serum inflammatory markers levels, in addition to 
traditional cardiovascular risk factors, in estimating cardiovascular risk in both adults and 
the youth populations. Both high circulating white cell counts and high serum high 
sensitivity C-reactive protein (hsCRP) are associated with increased risk of diabetes and 
associated complications in adults (113, 114). Increasing clinical evidence also suggest a link 
between inflammation, insulin resistance and cardiovascular risk factors in children and 
adolescents (13, 115-117). In a school children study including over 2,000 Hong Kong 
Chinese adolescents (median age: 16 years), overweight/obesity was associated with two to 
six-fold increased risk of having high hsCRP tertiles(13). In another cross-sectional study 
including 326 obese children aged 6-12 years (mean age 8.9 years), white blood cell counts 
were associated with plasma lipid profile (triglyceride, total and LDL cholesterol) and 
obesity indices (body mass index and WC)(117). 
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3.3 Heavy metals and environmental pollutants 
Apart from changes in habits and lifestyle, exposure to heavy metals is increasingly 
recognized as a consequence of urbanization. Most heavy metals cannot be metabolized by 
our body, and excessive accumulation in the body will disturb the normal functions of cells. 
Kidney is the key organ to eliminate heavy metals from the body. Heavy metals might lead 
to albuminuria through inducing oxidative stress to renal tubular cells(118, 119). Certain 
heavy metals have additive effect in inducing nephrotoxicity. For example, synergistic effect 
of arsenic (As) and cadmium (Cd) in causing renal damage has been demonstrated in 
Chinese general population(120). In addition, chronic exposure to toxic heavy metals may 
promote atherosclerosis and contribute to the development of chronic kidney disease and 
cardiovascular diseases (119, 121). Furthermore, air pollutants can provoke systemic pro-
inflammatory and pro-thrombotic response and lead to increase in platelet counts and 
platelet activation(122). The significance of platelet activation and whether anti-platelet 
therapies can help reducing cardiovascular risk profiles in the youth populations is still a 
debatable subject(123). Further studies are required to examine the impact of heavy metals 
and environmental pollutants, as novel cardiovascular risk factors, in accelerating the 
development of cardiovascular disease in both adults and the youth populations(124).  
4. Controversies and the unmet needs to be addressed 
Lifestyle modification including regular exercise and diet are cornerstones of management 
of traditional cardiovascular risk factors including obesity, diabetes, dyslipidemia and 
hypertension. With recent evidence demonstrating the importance of adequate sleep 
duration in adolescents, education for a healthy sleep habit becomes one of the essential 
targets of lifestyle modification to prevent cardiovascular risk factors in the youth. 
Childhood and adolescence are vulnerable periods for habit formation due to substantial 
tracking of lifestyle habits and cardiovascular risk from this period into adulthood (125, 
126). Thus, promoting healthy eating habit, regular exercise and healthy sleep habit in the 
youth are important strategies to curb the public health problem of obesity.  
The optimal dietary approach to combat obesity and reduce cardiovascular risk factors is 
still a matter of controversies. Indeed, modern food-processing technology produces many 
food products with high glycemic index (GI). There is now emerging evidence showing that 
both the quality and quantity of dietary components can impact upon various physiological 
processes underlying energy metabolism and control of satiety which can provide the basis 
for dietary intervention in diabetes and obesity (127, 128). Epidemiological studies from US 
and China indicate that the risks of chronic diseases such as type 2 diabetes and coronary heart 
disease are strongly related to dietary GI (129, 130). High GI food, especially rice, the main 
carbohydrate-contributing food in Chinese, may increase risk of diabetes (130). WHO and 
Food and Agriculture Organization (FAO) recommend low-GI diet to prevent common 
chronic diseases of affluence, including obesity and type 2 diabetes (131). Recently, it has been 
suggested that low GI diet may have a role in the management of childhood obesity(132).  
Promotion of regular exercise is another important aspect of lifestyle modifications in 
reducing cardiovascular risk in adolescents. Physical inactivity has been reported to be 
associated with obesity and other cardiovascular risk factors in adolescents(133). The role of 
exercise in weight management and control of cardiovascular risk factors is usually 
www.intechopen.com
 Novel and Traditional Cardiovascular Risk Factors in Adolescents 
 
69 
associated with its direct impact on energy expenditure and its potential to alter various 
components of appetite control and eating behavior. Low physical activity level predicts 
weight gain in different ethnic groups (134, 135). Regular physical activity maintains good 
health and prevents myocardial infarction, cardiovascular events and premature mortality 
(136, 137). Since early 1990s, many studies have demonstrated the beneficial effects of 
physical activity on promoting weight reduction and fat loss as well as reducing risk of 
diabetes and hypertension (138-141). Beneficial effects of exercise and diet are possibly 
beyond weight reduction. In a small scale study of obese Hong Kong Chinese children, 
combined intervention with diet and exercise reduced adiposity as well as improved lipid 
profiles and endothelial function compared to diet alone (25). In another study, a 6-week 
intervention with diet and strength training improved lipid profile in obese Chinese 
children (142).  
WHO recommends regular and accumulated physical activities to prevent premature death 
and other adverse health outcomes (143). However, there are ongoing debates on the 
optimal frequency, duration and intensity of physical activity. Most international guidelines 
recommend moderate activity in adults, especially those who are older and less active (136). 
In a systematic review of over 850 published literatures, the authors recommended ≥ 60 
minutes physical activity of moderate to vigorous level in school-age youth (144). In 1988, 
the American College of Sports Medicine first recommended children and adolescents to 
have 20-30 minutes of vigorous exercise daily (145). In 2007, the Regional Office for Europe 
of the WHO made similar recommendations (146). Other guidelines suggested physical 
activity of moderate intensity at least twice or more weekly to enhance and maintain 
muscular strength, flexibility and bone health (20) while others suggested high levels and 
long duration of regular exercise (e.g. daily physical activity lasting at least 90 minutes) in 
the youth population (147).  
As previously discussed, despite the escalating rate of diabetes and dyslipidemia in the 
youth population, therapeutic modalities remain limited with metformin and statin being 
the only US FDA approved oral treatment for youth with type 2 diabetes (61, 62) and 
dyslipidemia respectively (84, 85). More clinical researches are required to demonstrate the 
efficacy and safety for more therapeutic options in managing adolescents with type 2 
diabetes and dyslipidemia.  
5. Conclusion 
In conclusion, cardiovascular disease is an increasing world health problem. In view of the 
substantial tracking of cardiovascular risk factors from adolescents to adulthood, there is an 
urgent need to intervene early with efficacious strategies to identify and treat the youth with 
cardiovascular risk factors. The traditional cardiovascular risk factors, namely 
overweight/obesity, diabetes, hypertension and dyslipidemia do not account for all 
cardiovascular deaths and novel factors, including lifestyle (e.g. sleep deprivation) and 
environmental (e.g. heavy metal poisoning), as well as the consequences and interactions 
related to these traditional and novel risk factors (e.g. inflammation and platelet activation) 
appear to be important, accounting for the dramatic recent changes in prevalence and 
would be of public health concern. Moreover, more intensive program for lifestyle 
modification and aggressive approach of pharmacological treatment should be considered 
in the youth at-risk of cardiovascular events. 
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Fig. 1. Traditional and Novel Cardiovascular Risk Factors in Adolescents. 
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Cardiovascular risk factors contribute to the development of cardiovascular disease from early life. It is thus
crucial to implement preventive strategies addressing the burden of cardiovascular disease as early as
possible. A multidisciplinary approach to the risk estimation and prevention of vascular events should be
adopted at each level of health care, starting from the setting of perinatology. Recent decades have been
marked with major advances in this field, with the emergence of a variety of new inflammatory and immune-
mediated markers of heightened cardiovascular risk in particular. The current book reflects some of the
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estimation. It comprehensively covers primary and secondary preventive measures targeted at different age
and gender groups. Attention is paid to inflammatory and metabolic markers of vascular damage and to the
assessment of vascular function by noninvasive standardized ultrasound techniques. This is a must-read book
for all health professionals and researchers tackling the issue of cardiovascular burden at individual and
community level. It can also serve as a didactic source for postgraduate medical students.
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